Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Bad News - '336 Reexam Ordered

Nov 14, 2009 12:03PM
1
Nov 14, 2009 12:30PM
2
Nov 14, 2009 12:56PM
1
Nov 14, 2009 01:01PM
2
Nov 14, 2009 01:13PM
2
Nov 14, 2009 01:17PM
1
Nov 14, 2009 01:31PM

Nov 14, 2009 02:13PM

Now it is clear why the statement in the last PR about having to conserving cash. PTSC management knew that another rexam was going to be imminent, and being an expensive and drawn out process with an uncertain outcome they needed to conserve cash.

Now look for more dilution. First another item in the shareholder meeting to increase authorized by another 500 million. I bet they ask for shareholder vote on increasing the authorized to 5 billion shares. After the rexam conludes and if favourably I expect a 1:100 reverse split. By then the management would have given themselves handsome 'bonuses' for having 'steered the company through difficult times'. shareholders by the way were done in a long time ago

this is turning out to be a typical OTC/pink sheet 'promotion'

2
Nov 14, 2009 02:53PM

Nov 15, 2009 05:53PM
Share
New Message
Please login to post a reply